Effects of rosuvastatin on the metabolism of apolipoprotein B of VLDL1, VLDL2, IDL and LDL during type 2 diabetes

被引：0
|
作者：
Verges, B. [1 ]
Florentin, E. [2 ]
Baillot-Rudoni, S.
Monnier, S. [2 ]
Petit, J. M.
Gambert, P. [2 ]
Duvillard, L. [2 ]
机构：
[1] Complexe Hosp Bocage, Dijon, France
[2] Ctr Hosp Univ, INSERM, Cri 866, Dijon, France
来源：
DIABETES & METABOLISM | 2008年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O94
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [1] Liraglutide accelerates the catabolism of apolipoprotein B100 containing lipoproteins (VLDL1, VLDL2, IDL and LDL) in patients with type 2 diabetes: an in vivo kinetic study
    Verges, B.
    Bouillet, B.
    Rouland, A.
    Baillot-Rudoni, S.
    Buffier, P.
    Crevisy, E.
    Petit, J.
    Duvillard, L.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S118 - S118
  • [2] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects
    Malmström, R
    Packard, CJ
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (05) : 779 - 787
  • [3] Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
    Rakel F. Johansen
    Esben Søndergaard
    Lars Peter Sørensen
    Anne Grethe Jurik
    Jens S. Christiansen
    Søren Nielsen
    Diabetologia, 2016, 59 : 833 - 843
  • [4] Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
    Johansen, Rakel F.
    Sondergaard, Esben
    Sorensen, Lars Peter
    Jurik, Anne Grethe
    Christiansen, Jens S.
    Nielsen, Soren
    DIABETOLOGIA, 2016, 59 (04) : 833 - 843
  • [5] VLDL1 and VLDL2 Triglyceride Kinetics in Type 2 Diabetic and Healthy Men
    Johansen, Rakel F.
    Sondergaard, Esben
    Sorensen, Lars Peter
    Jurik, Anne Grethe
    Christiansen, Jens S.
    Nielsen, Soren
    DIABETES, 2015, 64 : A175 - A175
  • [6] Variation in dietary carbohydrate to fat ratio alters distribution of triglyderides in VLDL1 and VLDL2 without altering apolipoprotein B metabolism
    Bisschop, PH
    Ackermans, NT
    De Sain-Van der Velden, MGM
    Barrett, PHR
    Endert, E
    Kuipers, F
    Sauerwein, HP
    Romijn, JA
    DIABETES, 2002, 51 : A599 - A600
  • [7] Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-apoB kinetics in type 2 diabetes
    Verges, B.
    Duvillard, L.
    Chadarevian, R.
    Baillot-Rudoni, S.
    Petit, J.-M.
    Florentin, E.
    Princep, L.
    Gambert, P.
    DIABETOLOGIA, 2007, 50 : S504 - S504
  • [8] Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
    Verges, B.
    Florentin, E.
    Baillot-Rudoni, S.
    Monier, S.
    Petit, J. M.
    Rageot, D.
    Garnbert, P.
    Duvillard, L.
    DIABETOLOGIA, 2008, 51 (08) : 1382 - 1390
  • [9] Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
    B. Vergès
    E. Florentin
    S. Baillot-Rudoni
    S. Monier
    J. M. Petit
    D. Rageot
    P. Gambert
    L. Duvillard
    Diabetologia, 2008, 51 : 1382 - 1390
  • [10] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects (vol 47, pg 779, 1998)
    Malmström, R
    Packard, C
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (09) : 1532 - 1532
12345